In vivo analyses using transgenic APL mice models with PML-RARA have revealed that a population of committed myeloid progenitor cells (CD34+, c-kit+, FcγRIII/II+, Gr1int) was identified as the APL-LIC [13], [14]. The gene discussed is CD34; the disease is acute promyelocytic leukemia.